Daré Bioscience, Inc.: Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...
manilatimes3d
Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
Daré will host a conference call and live webcast today, November 14, 2024, at 4:30 p.m. Eastern Time to review financial ...
Daily5d
For Moderate to Severe acne, CAB gel turns out to be effective treatment. Study
For Moderate to Severe acne, CAB gel turns out to be effective treatment suggests a study published in the Journal of Drugs ...